# IMAGENOMIX CORP.: Analytical Variables and Clinical Utility of AKT1 Mutation Prediction in Breast Cancer Using Deep Learning on Histopathology Images

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | IMAGENOMIX CORP. |
| Location | BROOKLYN, NY |
| Project | Analytical Variables and Clinical Utility of AKT1 Mutation Prediction in Breast Cancer Using Deep Learning on Histopathology Images |
| Project number | 1R43CA309961-01 |
| Mechanism | R43 |
| Institute | National Cancer Institute |
| Award | $157,826 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-18 to 2028-08-31 |
| UEI | WB3ZA2P5QNF3 |

## Why this score
- Award of $157,826.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11312149). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.